Aligos Therapeutics, Inc. (ALGS)
9.50
+0.38
(+4.17%)
USD |
NASDAQ |
Dec 31, 13:41
Aligos Therapeutics Price: 9.50 for Dec. 31, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CEL-SCI Corp. | 5.36 |
| AIM ImmunoTech, Inc. | 1.11 |
| IGC Pharma, Inc. | 0.2815 |
| NovaBay Pharmaceuticals, Inc. | 5.51 |
| Protalix Biotherapeutics, Inc. | 1.775 |
Price Related Metrics
| PS Ratio | 32.05 |
| PEG Ratio | -0.01 |
| Price to Book Value | 0.8139 |
| Earnings Yield | -208.0% |
| Market Cap | 58.46M |
| PEGY Ratio | -0.01 |